Drug intelligence / Profile preview

CelaGel

Development stage: Preclinical
Lead developer: CelaCare Technologies
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

**CelaGel** is a proprietary topical antimicrobial hydrogel being developed by CelaCare for application to surgical sites and wounds, including prevention or management of surgical site infections associated with oncology procedures. The product is described as combining a silver citrate complex with acemannan, an Aloe vera-derived polysaccharide; the silver component is intended to provide broad antimicrobial activity, while acemannan is intended to support tissue repair and wound healing. CelaCare's related patented hydrogel technology describes a silver salt plus Aloe vera-derived material for antimicrobial wound and burn treatment. ([patents.google.com](https://patents.google.com/patent/WO2012151438A1/en))

Other names: CelaGelCelaGel Antimicrobial Hydrogel

Beyond the preview

Go deeper on CelaGel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CelaGel.

Explore the full profile